The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of a SNP panel to refine risk estimates in women at high risk of breast cancer: Results from two randomized tamoxifen prevention trials.
Jack M. Cuzick
No relevant relationships to disclose
Adam Brentnall
No relevant relationships to disclose
Corrinne Segal
No relevant relationships to disclose
Ivana Sestak
No relevant relationships to disclose
Roseann Kealy
No relevant relationships to disclose
Anthony Howell
No relevant relationships to disclose
Trevor J. Powles
No relevant relationships to disclose
Nicholas Orr
No relevant relationships to disclose
William G. Newman
No relevant relationships to disclose
Mitchell Dowsett
No relevant relationships to disclose